Skip to main content
. 2016 May 9;7(8):5559–5567. doi: 10.1039/c6sc00481d

Fig. 2. (A–D) Cellular toxicity of α-TOS, T-α-TOS-NPs, and NT-α-TOS-NPs in different cancer cell lines. (E) Relatively lower cytotoxic effects of α-TOS, T-α-TOS-NPs, and NT-α-TOS-NPs in normal H9C2 cardiomyocytes. (F) A comparison of toxicity of α-TOS, T-α-TOS-NPs, NT-α-TOS-NPs in cancer and normal cells. ***P < 0.001; **P = 0.001–0.01; *P < 0.05.

Fig. 2